U.S., July 25 -- ClinicalTrials.gov registry received information related to the study (NCT07084181) titled 'Fitbit Assessed PS in Colorectal Cancer' on July 16.
Brief Summary: Primary Objective
To assess the feasibility of activity tracking using Fitbit device in terms of compliance (defined as at least 75% of patients complying with instructions to wear the device, for at least 12 hours a day on at least 3 of the 4 assigned days) in patients undergoing therapy for localized and advanced colorectal cancer.
Secondary Objectives
* To determine if physician-assessed performance status correlates with FitbitTM assessed physical activity (using active-minutes data).
* To correlate baseline physical activity level as assessed by FitbitTM wi...